Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mTOR-driven cancers, today announced poster...

Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage immunology company, today announced it will be providing updates on its RNA immunotherapies at multiple presentations at the American...

-Sapience to present data across its pipeline, including non-clinical immunotherapy results on ST316 and ST101 and preclinical results on its novel AP-1 complex antagonist TARRYTOWN, N.Y., March...

GV20 Therapeutics, a clinical-stage biotechnology company integrating AI, genomics, and disease biology to create next-generation antibody therapeutics for cancer, announced today that its...

Celsius Holdings, Inc., (Nasdaq: CELH), maker of Celsius®, the premium lifestyle energy drink formulated to power active lifestyles with ESSENTIAL ENERGY™, today announced that the company will...